Skip to main content
رجوع
ZYME logo

Zymeworks Inc.

جودة البيانات: 100%
ZYME
NASDAQ Healthcare Biotechnology
KWD 23.60
▼ KWD 0.42 (-1.75%)
القيمة السوقية: 1.75B
نطاق اليوم
KWD 23.23 KWD 23.91
نطاق 52 أسبوعًا
KWD 9.03 KWD 28.49
حجم التداول
480,424
متوسط 50 يوم / 200 يوم
KWD 23.44 / KWD 19.06
الإغلاق السابق
KWD 24.02

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Healthcare (627 نظير)

المقياس السهم وسيط القطاع
P/E -21.6 0.4
P/B 6.5 2.9
ROE % -26.7 3.7
Net Margin % -76.6 3.9
Rev Growth 5Y % 41.2 10.0
D/E 0.1 0.2

السعر المستهدف للمحللين

Hold
KWD 34.670 +46.9%
Low: KWD 26.000 High: KWD 40.000
مكرر الربحية المستقبلي
20.3
ربحية السهم المستقبلية
KWD 1.186
نمو ربحية السهم (تقدير)
+0.0%
الإيرادات المقدّرة
290 M

تقديرات الأرباح

الفترة تقدير ربحية السهم تقدير الإيرادات المحللون
FY2030 KWD 0.920
KWD 0.230 – KWD 1.736
390 M 2
FY2029 KWD 0.582
KWD 0.145 – KWD 1.098
300 M 4
FY2028 KWD 0.035
-KWD 0.263 – KWD 0.344
180 M 6

النقاط الرئيسية

Revenue grew 41.17% annually over 5 years — strong growth
Debt/Equity of 0.07 — conservative balance sheet
Negative free cash flow of -34.53M
PEG of 0.73 suggests growth is underpriced
Capital efficient — spends only 1.44% of revenue on capex

النمو

Revenue Growth (5Y)
41.17%
Revenue (1Y)38.87%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

الجودة

Return on Equity
-26.72%
ROIC-24.20%
Net Margin-76.56%
Op. Margin-87.34%

الأمان

Debt / Equity
0.07
Current Ratio5.52
Interest Coverage0.00

التقييم

P/E Ratio
-21.61
P/B Ratio6.53
EV/EBITDAN/A
Dividend Yield0.00%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 38.87% Revenue Growth (3Y) 18.07%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) 41.17% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 105.97M Net Income (TTM) -81.13M
ROE -26.72% ROA -23.41%
Gross Margin 89.81% Operating Margin -87.34%
Net Margin -76.56% Free Cash Flow (TTM) -34.53M
ROIC -24.20% FCF Growth (3Y) N/A
Safety
Debt / Equity 0.07 Current Ratio 5.52
Interest Coverage 0.00 Dividend Yield 0.00%
Valuation
P/E Ratio -21.61 P/B Ratio 6.53
P/S Ratio 16.55 PEG Ratio 0.73
EV/EBITDA N/A Dividend Yield 0.00%
Market Cap 1.75B Enterprise Value 1.73B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 105.97M 76.30M 76.01M 412.48M 26.68M
Net Income -81.13M -122.70M -118.67M 124.34M -211.84M
EPS (Diluted) -1.08 -1.62 -1.72 1.90 -4.61
Gross Profit 95.17M 76.30M -66.98M 412.48M 26.68M
Operating Income -92.55M -137.11M -138.05M 130.53M -215.63M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 346.53M 463.09M 580.88M 648.73M 389.13M
Total Liabilities 78.03M 124.32M 116.07M 155.77M 140.04M
Shareholders' Equity 268.50M 338.77M 464.81M 492.96M 249.09M
Total Debt 18.27M 18.51M 26.72M 28.11M 32.33M
Cash & Equivalents 41.16M 66.10M 157.56M 400.91M 201.87M
Current Assets 233.44M 300.45M 412.93M 544.71M 288.22M
Current Liabilities 42.32M 88.29M 55.76M 95.63M 71.85M

درجات الاستراتيجيات

This stock passed the criteria for 1 strategy

Score = fit strength (0–100)
Rank = position among all matches
Custom Full Throttle
#48 of 147
54

النشاط الأخير

دخل Full Throttle
Mar 24, 2026